Zsolt Farkas of Evolut on why today’s longevity valuations only work if the winners spend the next decade buying everything around them.
Link as first comment.

Zsolt Farkas of Evolut on why today’s longevity valuations only work if the winners spend the next decade buying everything around them.
Link as first comment.
Retension Pharmaceuticals, Inc. filed for an IPO
Retension Pharmaceuticals has filed for an IPO, focusing on treatments for hypertension. Their lead candidate, RTN-001, is designed to…
Biotech
#IPO #Biotech #PharmaceuticalPreparations #UnitedStates #IPONews #pharmaceuticals #cardiovascular
I’ll be at the World Vaccine Congress Europe in Amsterdam this month, 19-21 October
Looking forward to reconnecting with colleagues, discovering new vaccine programmes, and meeting biotech teams.
Let's meet
A Tokyo startup called TIME TRAVELER thinks the antiaging answer was sitting in the vegetable drawer all along.
Link as first comment.
TRex Bio, Inc. filed for an IPO
TRex Bio, Inc., a US-based biotech company, has filed for an IPO. They specialize in partnerships within the field, generating revenue from collaborative agreements.
Biotech
#IPO #Biotech #BiologicalProductsNoDiagnostic #UnitedStates #IPONews #biologicalproducts
$MONY.P and Vimy Pharmaceuticals sign a definitive RTO agreement after Vimy closes a C$12.06M financing. Its generic semaglutide submission remains under Health Canada review.
Disclaimer: This is NOT a financial advice
@medinadiscovery.bsky.social is back from BIOSPAIN2026! We were thrilled to take part in one of the leading partnering events in the biotechnology sector.
#BIOSPAIN2026 #Biotech #LifeSciences #Innovation #Collaboration #DrugDiscovery
The AI drug developer nominated ISM1354 for obesity, and says early lab and animal data point to better exposure and a wider safety margin.
Link as first comment.
#healthcare #medicine #biotech
Another great talk by Sinica #podcast with Dr. Ruby Wang, whose new book, China Cure: The Rise of a Biotech, AI Medicine and Global Health Superpower Agenda Publishing, is out October 31, with a foreword by Kerry Brown.
www.sinicapodcast.com/p/from-baref...
Can 'molecular clocks' plus AI spot cancer early? The 2026 evidence is promising but mixed. What the data shows:
Signal or noise? > Stocktwits Pharma Pulse: Roche Faces FDA Decision,
Gene-Therapy Stocks Step Into Focus — The Week’s Biotech Watchlist
- Yahoo Finance >> Comment below! #strategy #competitiveintelligence #marketing #pharmaceutical #pharma #biotech #competitivemarketing #healthcare
Ascletis' oral IL-17A inhibitor ASC50 posted early Phase 1 data in plaque psoriasis: a 48.9% placebo-adjusted PASI reduction after 28 days. Small study, milder patients, more work ahead.
#Biotech #Biotechnology #Phase1
Disclaimer: This is NOT a financial advice
📘 BIOTECH PATENT STRATEGY MADE SIMPLE: A Practical Guide to Protecting, Managing, and Monetizing Biotechnology Innovations
#biotechnology #Biotech #patents #intellectualpropertyrights #BiotechStartups #PatentStrategy #IPStrategy #lifesciences Book link: a.co/d/00tzJ6Z2
🔬 Biotech M&A is roaring back. AbbVie's acquisition of Apogee Therapeutics signals renewed confidence in pharmaceutical deal-making after an extended slowdown. Recent Phas… #2026 #AbbVie #ApogeeTherapeutics #Biotech #Clinicaltrials #2026 #AbbVie #ApogeeTherapeutics #Biotech #Clinicaltrials htt…
We can edit DNA.
We can manufacture RNA.
But I didn’t perfect the immortality serum in my garage.
Breaking biological limits isn’t defeating death.
It’s moving the boundary from “impossible” to “not yet”.
wp.me/pgsIo5-iV
#Longevity #Biotech #Science #Medicine #mRNA #Future #Genetics
Signal or noise? > Gene therapy restored neural connections in adult dogs’
retinas — ScienceAlert - UA.NEWS >> Comment below! #strategy #competitiveintelligence #marketing #healthcare #pharma #competitivemarketing #pharmaceutical #biotech
"We're so close to the tech companies": Genentech CEO talks Fierce through vision for the future | #biotech #biotechsky #pharma